Profiles and technological requirements of urogenital probiotics
- Autores
- Nader, Maria Elena Fatima; Juárez Tomás, María Silvina
- Año de publicación
- 2015
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Probiotics, defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, are considered a valid and novel alternative for the prevention and treatment of female urogenital tract infections. Lactobacilli, the predominant microorganisms of the healthy human vaginal microbiome, can be included as active pharmaceutical ingredients in probiotics products. Several requirements must be considered or criteria fulfilled during the development of a probiotic product or formula for the female urogenital tract. This review deals with the main selection criteria for urogenital probiotic microorganisms: host specificity, potential beneficial properties, functional specifications, technological characteristics and clinical trials used to test their effect on certain physiological and pathological conditions. Further studies are required to complement the current knowledge and support the clinical applications of probiotics in the urogenital tract. This therapy will allow the restoration of the ecological equilibrium of the urogenital tract microbiome as well as the recovery of the sexual and reproductive health of women.
Fil: Nader, Maria Elena Fatima. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; Argentina
Fil: Juárez Tomás, María Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; Argentina - Materia
-
PROBIOTICS
PHARMABIOTICS
FEMALE UROGENITAL TRACT
UROGENITAL TRACT INFECTIONS
POTENTIAL BENEFICIAL PROPERTIES
TECHNOLOGICAL CHARACTERISTICS
CLINICAL ASSAYS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/16922
Ver los metadatos del registro completo
id |
CONICETDig_3b07724892e3dadc6aa905eab4832d67 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/16922 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Profiles and technological requirements of urogenital probioticsNader, Maria Elena FatimaJuárez Tomás, María SilvinaPROBIOTICSPHARMABIOTICSFEMALE UROGENITAL TRACTUROGENITAL TRACT INFECTIONSPOTENTIAL BENEFICIAL PROPERTIESTECHNOLOGICAL CHARACTERISTICSCLINICAL ASSAYShttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Probiotics, defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, are considered a valid and novel alternative for the prevention and treatment of female urogenital tract infections. Lactobacilli, the predominant microorganisms of the healthy human vaginal microbiome, can be included as active pharmaceutical ingredients in probiotics products. Several requirements must be considered or criteria fulfilled during the development of a probiotic product or formula for the female urogenital tract. This review deals with the main selection criteria for urogenital probiotic microorganisms: host specificity, potential beneficial properties, functional specifications, technological characteristics and clinical trials used to test their effect on certain physiological and pathological conditions. Further studies are required to complement the current knowledge and support the clinical applications of probiotics in the urogenital tract. This therapy will allow the restoration of the ecological equilibrium of the urogenital tract microbiome as well as the recovery of the sexual and reproductive health of women.Fil: Nader, Maria Elena Fatima. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; ArgentinaFil: Juárez Tomás, María Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; ArgentinaElsevier Science2015-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/16922Nader, Maria Elena Fatima; Juárez Tomás, María Silvina; Profiles and technological requirements of urogenital probiotics; Elsevier Science; Advanced Drug Delivery Reviews; 92; 9-2015; 84-1040169-409X1872-8294enginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.addr.2015.03.016info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0169409X15000551info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:33:11Zoai:ri.conicet.gov.ar:11336/16922instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:33:12.124CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Profiles and technological requirements of urogenital probiotics |
title |
Profiles and technological requirements of urogenital probiotics |
spellingShingle |
Profiles and technological requirements of urogenital probiotics Nader, Maria Elena Fatima PROBIOTICS PHARMABIOTICS FEMALE UROGENITAL TRACT UROGENITAL TRACT INFECTIONS POTENTIAL BENEFICIAL PROPERTIES TECHNOLOGICAL CHARACTERISTICS CLINICAL ASSAYS |
title_short |
Profiles and technological requirements of urogenital probiotics |
title_full |
Profiles and technological requirements of urogenital probiotics |
title_fullStr |
Profiles and technological requirements of urogenital probiotics |
title_full_unstemmed |
Profiles and technological requirements of urogenital probiotics |
title_sort |
Profiles and technological requirements of urogenital probiotics |
dc.creator.none.fl_str_mv |
Nader, Maria Elena Fatima Juárez Tomás, María Silvina |
author |
Nader, Maria Elena Fatima |
author_facet |
Nader, Maria Elena Fatima Juárez Tomás, María Silvina |
author_role |
author |
author2 |
Juárez Tomás, María Silvina |
author2_role |
author |
dc.subject.none.fl_str_mv |
PROBIOTICS PHARMABIOTICS FEMALE UROGENITAL TRACT UROGENITAL TRACT INFECTIONS POTENTIAL BENEFICIAL PROPERTIES TECHNOLOGICAL CHARACTERISTICS CLINICAL ASSAYS |
topic |
PROBIOTICS PHARMABIOTICS FEMALE UROGENITAL TRACT UROGENITAL TRACT INFECTIONS POTENTIAL BENEFICIAL PROPERTIES TECHNOLOGICAL CHARACTERISTICS CLINICAL ASSAYS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.4 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Probiotics, defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, are considered a valid and novel alternative for the prevention and treatment of female urogenital tract infections. Lactobacilli, the predominant microorganisms of the healthy human vaginal microbiome, can be included as active pharmaceutical ingredients in probiotics products. Several requirements must be considered or criteria fulfilled during the development of a probiotic product or formula for the female urogenital tract. This review deals with the main selection criteria for urogenital probiotic microorganisms: host specificity, potential beneficial properties, functional specifications, technological characteristics and clinical trials used to test their effect on certain physiological and pathological conditions. Further studies are required to complement the current knowledge and support the clinical applications of probiotics in the urogenital tract. This therapy will allow the restoration of the ecological equilibrium of the urogenital tract microbiome as well as the recovery of the sexual and reproductive health of women. Fil: Nader, Maria Elena Fatima. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; Argentina Fil: Juárez Tomás, María Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Centro de Referencia Para Lactobacilos; Argentina |
description |
Probiotics, defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, are considered a valid and novel alternative for the prevention and treatment of female urogenital tract infections. Lactobacilli, the predominant microorganisms of the healthy human vaginal microbiome, can be included as active pharmaceutical ingredients in probiotics products. Several requirements must be considered or criteria fulfilled during the development of a probiotic product or formula for the female urogenital tract. This review deals with the main selection criteria for urogenital probiotic microorganisms: host specificity, potential beneficial properties, functional specifications, technological characteristics and clinical trials used to test their effect on certain physiological and pathological conditions. Further studies are required to complement the current knowledge and support the clinical applications of probiotics in the urogenital tract. This therapy will allow the restoration of the ecological equilibrium of the urogenital tract microbiome as well as the recovery of the sexual and reproductive health of women. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/16922 Nader, Maria Elena Fatima; Juárez Tomás, María Silvina; Profiles and technological requirements of urogenital probiotics; Elsevier Science; Advanced Drug Delivery Reviews; 92; 9-2015; 84-104 0169-409X 1872-8294 |
url |
http://hdl.handle.net/11336/16922 |
identifier_str_mv |
Nader, Maria Elena Fatima; Juárez Tomás, María Silvina; Profiles and technological requirements of urogenital probiotics; Elsevier Science; Advanced Drug Delivery Reviews; 92; 9-2015; 84-104 0169-409X 1872-8294 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.addr.2015.03.016 info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0169409X15000551 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier Science |
publisher.none.fl_str_mv |
Elsevier Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613017760694272 |
score |
13.070432 |